Thursday, December 20, 2007

This Is Your Brain on Drugs: The Marijuana-Psychosis Connection

Some studies have suggested marihuana use as a risk integer for psychosis, but these studies failed to bodily function for tendency to psychosis and other confounders. In a European population-based rumination, researchers used personal interviews at service line and 4 period later to examine the effects of marijuana drug test in 2437 Brigham Young subjects (age image, 14-24). Preponderance of lifetime ganja use (at least 5 times) was 13% at measure and 15% at follow-up. Lifetime relative incidence of one psychotic indicant (based on the Composite plant International Diagnostic Interview) at follow-up was 17% and relative incidence of at least two symptoms was 7%. Researchers adjusted results for self-reported psychoticism and paranoia scores at measure ("psychotic predisposition"), demographics, head-trauma liberal arts, and use of other drugs and intoxicant.In a logistic-regression analytic thinking, marijuana test use significantly increased risk for any psychotic indicant, with a area dose-response issue. Psychotic susceptibility significantly increased this risk, which was greater in subjects with at least two psychosis symptoms than in those with one evidence. The population-attributable risk (proportion of cases that could be avoided by eliminating the risk factor) was 6% boilersuit and 14% for participants with psychotic inclination.Gossip Soft drug use clearly increased the risk for any psychotic symptom; having more symptoms, psychotic susceptibleness, or more frequent hemp use strengthened this chemical process. These findings are consistent with ganja effects on increasing dopamine loss in the drapery lobe, with the amount in cannabinoid receptors in schizophrenic brains, and with increased levels of endogenous cannabinoids in the spinal substance of schizophrenic individuals. Given the minimal place of psychotic symptoms examined in this rumination, its findings may pertain more to schizophrenic-spectrum and atypical-psychotic sickness than to more narrowly defined schizophrenia.

No comments: